Terms: = Liver cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Staging
6 results:
1. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
[TBL] [Abstract] [Full Text] [Related]
2. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
Mei J; Lin WP; Shi F; Wei W; Liang JB; Shi M; Zheng L; Li SH; Guo RP
Eur J Radiol; 2021 Sep; 142():109890. PubMed ID: 34375811
[TBL] [Abstract] [Full Text] [Related]
4. Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series Data.
Fankhauser CD; Grogg JB; Hayoz S; Wettstein MS; Dieckmann KP; Sulser T; Bode PK; Clarke NW; Beyer J; Hermanns T
J Urol; 2020 May; 203(5):949-956. PubMed ID: 31845841
[TBL] [Abstract] [Full Text] [Related]
5. Expression of hepatic Wnt5a and its clinicopathological features in patients with hepatocellular carcinoma.
Wang L; Yao M; Fang M; Zheng WJ; Dong ZZ; Pan LH; Zhang HJ; Yao DF
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):227-232. PubMed ID: 29709351
[TBL] [Abstract] [Full Text] [Related]
6. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract] [Full Text] [Related]
